B-Type Natriuretic Peptide: Spectrum of Application. Nesiritide (Recombinant BNP) for Heart Failure

[1]  G. Fonarow.  Pharmacologic therapies for acutely decompensated heart failure. , 2002, Reviews in cardiovascular medicine.

[2]  James B. Young.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial , 2002 .

[3]  J. Ghali,et al.  Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. , 2002, Journal of the American College of Cardiology.

[4]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[5]  P. Poole‐Wilson.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. , 2002 .

[6]  A. Burger,et al.  Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. , 2001, The American journal of cardiology.

[7]  M. Creager.  Beta-blockers for vascular surgery and angioplasty for renal artery stenosis. , 2001, Reviews in cardiovascular medicine.

[8]  R. Bourge,et al.  Nesiritide: a unique therapeutic cardiac peptide. , 2001, Reviews in cardiovascular medicine.

[9]  T. LeJemtel,et al.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. , 2000, The New England journal of medicine.

[10]  J. Burnett,et al.  Natriuretic peptides in the pathophysiology of congestive heart failure , 2000, Current cardiology reports.

[11]  T. DeMarco,et al.  Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. , 1999, The American journal of physiology.

[12]  W. Abraham,et al.  Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. , 1998, Journal of cardiac failure.

[13]  D. Gardner,et al.  N ATRIURETIC P EPTIDES , 1998 .

[14]  G. Fonarow,et al.  Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. , 1997, Journal of the American College of Cardiology.

[15]  D. Heitjan,et al.  Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. , 1996, Circulation.

[16]  L. Miller,et al.  Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1996, The American journal of cardiology.